Looking to Partner with the World CNS Series?

Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2027 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.

If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.

World CNS Partnership Prospectus 2026

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Download Your Copy of the Sponsorship Prospectus

onsite image 2
Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of pain therapeutics

onsite image 3
Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider to pain drug developers

onsite image 4
Join Biopharma Experts

Network with pharma, biotech, VC, academia, advocacy and regulatory voices driving real-world adoption